Leukaemia UK is delighted to continue its investment and funding for early career scientists and clinicians in 2022.

In collaboration with our partners and as part of the One Cancer Voice group, Cancer 52 and Blood Cancer Alliance, we have called on the Government to take account of a wide range of recommendations as they finalise the 10-Year Cancer Plan to be announced later this year.

Leukaemia UK is delighted to announce the appointment of Chris Dew as Director of Finance & Resources, following ten years as Chief Financial Officer at musical therapy charity Nordoff-Robbins.  The…

A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.